These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 11217874)

  • 1. The role of fluoroquinolones in tuberculosis today.
    Berning SE
    Drugs; 2001; 61(1):9-18. PubMed ID: 11217874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluoroquinolones and tuberculosis.
    Bryskier A; Lowther J
    Expert Opin Investig Drugs; 2002 Feb; 11(2):233-58. PubMed ID: 11829714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prospects for development of new antituberculous drugs].
    Tomioka H
    Kekkaku; 2002 Aug; 77(8):573-84. PubMed ID: 12235850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activities of fourteen antimicrobial agents against drug susceptible and resistant clinical isolates of Mycobacterium tuberculosis and comparative intracellular activities against the virulent H37Rv strain in human macrophages.
    Rastogi N; Labrousse V; Goh KS
    Curr Microbiol; 1996 Sep; 33(3):167-75. PubMed ID: 8672093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility to levofloxacin of Myocobacterium tuberculosis isolates from patients with HIV-related tuberculosis and characterization of a strain with levofloxacin monoresistance. Community Programs for Clinical Research on AIDS 019 and the AIDS Clinical Trials Group 222 Protocol Team.
    Perlman DC; El Sadr WM; Heifets LB; Nelson ET; Matts JP; Chirgwin K; Salomon N; Telzak EE; Klein O; Kreiswirth BN; Musser JM; Hafner R
    AIDS; 1997 Oct; 11(12):1473-8. PubMed ID: 9342069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluoroquinolones for the treatment of pulmonary tuberculosis.
    Moadebi S; Harder CK; Fitzgerald MJ; Elwood KR; Marra F
    Drugs; 2007; 67(14):2077-99. PubMed ID: 17883288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population-based resistance of Mycobacterium tuberculosis isolates to pyrazinamide and fluoroquinolones: results from a multicountry surveillance project.
    Zignol M; Dean AS; Alikhanova N; Andres S; Cabibbe AM; Cirillo DM; Dadu A; Dreyer A; Driesen M; Gilpin C; Hasan R; Hasan Z; Hoffner S; Husain A; Hussain A; Ismail N; Kamal M; Mansjö M; Mvusi L; Niemann S; Omar SV; Qadeer E; Rigouts L; Ruesch-Gerdes S; Schito M; Seyfaddinova M; Skrahina A; Tahseen S; Wells WA; Mukadi YD; Kimerling M; Floyd K; Weyer K; Raviglione MC
    Lancet Infect Dis; 2016 Oct; 16(10):1185-1192. PubMed ID: 27397590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluoroquinolones for treating tuberculosis.
    Ziganshina LE; Vizel AA; Squire SB
    Cochrane Database Syst Rev; 2005 Jul; (3):CD004795. PubMed ID: 16034951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinically significant interactions with drugs used in the treatment of tuberculosis.
    Yew WW
    Drug Saf; 2002; 25(2):111-33. PubMed ID: 11888353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infection caused by Mycobacterium tuberculosis.
    Peloquin CA; Berning SE
    Ann Pharmacother; 1994 Jan; 28(1):72-84. PubMed ID: 8123968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluoroquinolones for the treatment of tuberculosis in children.
    Thee S; Garcia-Prats AJ; Donald PR; Hesseling AC; Schaaf HS
    Tuberculosis (Edinb); 2015 May; 95(3):229-45. PubMed ID: 25797610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluoroquinolones for treating tuberculosis.
    Ziganshina LE; Squire SB
    Cochrane Database Syst Rev; 2008 Jan; (1):CD004795. PubMed ID: 18254061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical use of Levofloxacin in the long-term treatment of drug resistant tuberculosis.
    Richeldi L; Covi M; Ferrara G; Franco F; Vailati P; Meschiari E; Fabbri LM; Velluti G
    Monaldi Arch Chest Dis; 2002 Feb; 57(1):39-43. PubMed ID: 12174702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergence during unsuccessful chemotherapy of multiple drug resistance in a strain of Mycobacterium tuberculosis.
    Rastogi N; Ross BC; Dwyer B; Goh KS; Clavel-Sérès S; Jeantils V; Cruaud P
    Eur J Clin Microbiol Infect Dis; 1992 Oct; 11(10):901-7. PubMed ID: 1362540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuberculosis pharmacotherapy: strategies to optimize patient care.
    Mitnick CD; McGee B; Peloquin CA
    Expert Opin Pharmacother; 2009 Feb; 10(3):381-401. PubMed ID: 19191677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical evaluation of new quinolones as antituberculosis drugs].
    Kawahara S; Tada A; Nagare H
    Kekkaku; 1999 Jan; 74(1):71-5. PubMed ID: 10067058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New drugs for tuberculosis.
    Grassi C; Peona V
    Eur Respir J Suppl; 1995 Sep; 20():714s-718s. PubMed ID: 8590571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Half of rifampicin-resistant Mycobacterium tuberculosis complex isolated from tuberculosis patients in Sub-Saharan Africa have concomitant resistance to pyrazinamide.
    Ngabonziza JCS; Diallo AB; Tagliani E; Diarra B; Kadanga AE; Togo ACG; Thiam A; de Rijk WB; Alagna R; Houeto S; Ba F; Dagnra AY; Ivan E; Affolabi D; Schwoebel V; Trebucq A; de Jong BC; Rigouts L; Daneau G;
    PLoS One; 2017; 12(10):e0187211. PubMed ID: 29088294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.